Your browser doesn't support javascript.
loading
A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development.
Draghiciu, Oana; Boerma, Annemarie; Hoogeboom, Baukje Nynke; Nijman, Hans W; Daemen, Toos.
Afiliação
  • Draghiciu O; Department of Medical Microbiology; Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen ; Groningen, The Netherlands.
  • Boerma A; Department of Medical Microbiology; Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen ; Groningen, The Netherlands.
  • Hoogeboom BN; Department of Medical Microbiology; Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen ; Groningen, The Netherlands.
  • Nijman HW; Department of Gynecology; University of Groningen; University Medical Center Groningen ; Groningen, The Netherlands.
  • Daemen T; Department of Medical Microbiology; Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen ; Groningen, The Netherlands.
Oncoimmunology ; 4(10): e1029699, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26451295
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda